Navigation Links
AstraZeneca Among Working Mother Magazine's 2009 'Best Companies'
Date:9/22/2009

WILMINGTON, Del., Sept. 22 /PRNewswire-FirstCall/ --- AstraZeneca (NYSE: AZN) has been recognized as one of the 2009 Working Mother 100 Best Companies for the eighth consecutive year. This award acknowledges the company's commitment to family-friendly policies that support employee retention, employee engagement, and career advancement.

This year, the company was recognized specifically for its best practices in parental leave and training and development. AstraZeneca provides each eligible employee with up to 52 weeks of combined paid and unpaid leave, 26 weeks of which is job guaranteed, to care for their newborn child, adopted or foster child. The company also offers paid adoption leave.

In training and development, the company expanded the IDEA program, which provides short term development opportunities to enable individuals to develop new skills and explore alternate careers through work experience in different areas within the company while staying in their current position. The program matches employees who want to learn and have skills to share with host project managers.

"AstraZeneca strives to create an inclusive culture of innovation and opportunity to help employees manage the growing demands of work and personal life," says Marta Brito Perez, Vice President, Human Resources, North America & Global Marketing. "This recognition from Working Mother magazine underscores our commitment to the health and welfare of our employees."

Additional programs the company offers include:

  • Childcare and eldercare resources, services and discounts
  • Flexible work arrangements
  • Work/life seminars
  • Employee Assistance Program providing confidential, personal support, resources and referrals
    '/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., Association Discusses Key Provisions of Legisl...Reform ,, ST. CHARLES, Ill., Nov. 21 /PRNewswi...ntatives passing the landmark Affordable Health Ca...ing key health reform legislation forward, Congres...ken health care system. Today, AARP hosted an edu...
(Date:11/21/2009)... Eric J. Hall, president and chief...f America (AFA) issued the following statement reg...tion as part of the new annual wellness for Medica...nd Affordable Care Act" that was introduced l... (PRWEB) November 21, 2009 -- Eric J. Hall, presid...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 ...enators to modify health care reform legislation r...arding a health insurance individual coverage mand...rceable mandate will minimize adverse selection st...s prescribed by the bill. ,, "The individual ma...
(Date:11/20/2009)..., CHICAGO, Nov. 20 The ...U.S. Food and Drug Administration (FDA) to establi... chemicals. ,, Citing concern about the safety... without the benefit of professional consultation ...that the application of chemically based tooth whi...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ...d that it will broadcast Doctor Radio Reports: ...an in-depth special hosted by veteran journalist P...cgi-bin/prnh/20080819/NYTU044LOGO ) ,, Doctor ...out Mammograms will air November 21 live at 10:...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
... Academy,of Physician Assistants (AAPA), represent...icing in the U.S., is pleased to join other nation...rvice-sponsored guidelines,on Treating Tobacco Use...s and other health,care professionals in treating ...
...stCall/ - NUCRYST Pharmaceuticals,a developer and ...ion and,inflammation, today announced the appointm...Financial Officer, effective May 8, 2008. In these...s E. Gardner, Chairman and Chief Executive Officer...
...ive form of the disease, researchers report , ... first time, a gene linked to the often fatal chil...searchers report. , "This is the first paper that ...t The Children,s Hospital of Philadelphia. "We exp...
...es, Inc.,(OTC Bullentin Board: DSCI), provider of ...lease its first quarter 2008 results before market...a conference call that same,day to discuss the res...l. You may also access this call via the Internet,...
...Act seeks to accelerate development of ne..., SAN FRANCISCO and WASHINGTON, May 7 A,bipartis...gress introduced,today the National Neurotechnolog...ricans living with a brain-related,illness, injury...
..., DALLAS, May 7 The American Heart Association,h... its second of the,planned six-publication extensi...rnal of the American Heart Association. The journa...iology at,Tufts-New England Medical Center and ass...
Other Medicine News:Health News:AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence 2Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 2Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 3Health News:NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer 4Health News:Gene Variation Linked to Neuroblastoma, a Childhood Cancer 2Health News:Gene Variation Linked to Neuroblastoma, a Childhood Cancer 3Health News:Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008 2Health News:Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness 2Health News:Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness 3Health News:Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness 4Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 3
(Date:11/20/2009)...ov. 20 Reportlinker.com announces ...its catalogue. ,, Blood Pressure Monitoring &a...sis ,, http://www.reportlinker.com/p0164309/...---A-World-Market-Analysis.html#utm_source=prnewsw... ,, Measurement of blood pressure is not only ...
(Date:11/20/2009)...ov. 20 ,, Reportlinker.com anno...le in its catalogue. ,, Global Markets for Bre...linker.com/p0164741/Global-Markets-for-Breast-Biop..._medium=pr&utm_campaign=prnewswire ,, The... the spring loaded core needle market and vacuum a...
(Date:11/20/2009)... 20 Biotel Inc. (OTC Bul... quarter ended September 30, 2009 with net earning...nues of $3,263,000. This compares to net earnings...ues of $3,168,000 for the first quarter of last ye... Biotel President and CEO Steve Springrose said: "...
Breaking Medicine Technology:Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 2Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 3Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 4Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 5Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 6Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 7Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 8Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis 9Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Biotel Announced Profitable First Quarter Ended September 30, 2009 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 1Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 2Revenue Management Solutions LLC Receives EHNAC Financial Services Accreditation 54265 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 1Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 2Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 3Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 4Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 5Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 6Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 7Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 54261 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 1WuXi PharmaTech Announces Second Quarter 2009 Results 13509 2WuXi PharmaTech Announces Second Quarter 2009 Results 13509 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 4WuXi PharmaTech Announces Second Quarter 2009 Results 13509 5WuXi PharmaTech Announces Second Quarter 2009 Results 13509 6WuXi PharmaTech Announces Second Quarter 2009 Results 13509 7WuXi PharmaTech Announces Second Quarter 2009 Results 13509 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 9WuXi PharmaTech Announces Second Quarter 2009 Results 13509 10WuXi PharmaTech Announces Second Quarter 2009 Results 13509 11WuXi PharmaTech Announces Second Quarter 2009 Results 13509 12WuXi PharmaTech Announces Second Quarter 2009 Results 13509 13WuXi PharmaTech Announces Second Quarter 2009 Results 13509 14WuXi PharmaTech Announces Second Quarter 2009 Results 13509 15WuXi PharmaTech Announces Second Quarter 2009 Results 13509 16
...8 The Association,for Professionals in Infection ...at Rachel L. Stricof, MT, MPH, of Albany, NY, has ...arole DeMille Achievement Award.,APIC presents the...ol,professional who best exemplifies the ideals of...he award will be presented at the APIC 35th Annual...
...ena,Pharmaceuticals, Inc. (Nasdaq: ARNA ) announc... clinical trial of APD125 in patients with primary...ered by Arena with the,potential to reduce insomni...ty., The Phase 2b trial of APD125 is a double-bli...dy evaluating the efficacy and tolerability of,APD...
Other Medicine Technology:New York Infection Prevention Expert Named Recipient of Carole DeMille Award 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia 5
Trans-Blot Cell with Plate Electrodes
Criterion Gel/Wire Blot System
Criterion Gel/Plate Blot System
...to easily transfer proteins or nucleic acids from ...ell SureLock and XCell II Mini-Cells in place of t... 200 ml of transfer buffer for western Southern an...d stainless steel electrodes create a uniform elec...
Medicine Products: